SCHEMBL759746

SCHEMBL759746

CNc1csc(-c2cccs2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 0.58
RAB9A P51151 7/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
MAPT P10636 3/20 0.58
HPGD P15428 1/20 0.58
CASP3 P42574 1/20 0.58
SENP8 Q96LD8 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
LMNA P02545 1/20 0.48
CCNA2 P20248 1/20 0.47
CDK2 P24941 1/20 0.47
CCNA1 P78396 1/20 0.47
CDK5 Q00535 1/20 0.47
CDK5R1 Q15078 1/20 0.47
NPC1 O15118 7/20 0.44
ALDH1A1 P00352 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL299124 0.76 KDM4E (0.63) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL20322400 0.75 KDM4E (0.66) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL6675348 0.74 CDK5 (0.50) KDM4ERAB9AKMT2AMAPTHPGD
SCHEMBL10953155 0.74 HPGD (0.54) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL9829767 0.73 KDM4E (0.66) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL27935903 0.73 KDM4E (1.00) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL352098 0.72 KDM4E (0.68) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL2207730 0.72 KDM4E (0.63) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL5637098 0.72 KDM4E (0.63) KDM4ERAB9AMEN1KMT2AMAPT
SCHEMBL77482 0.71 KDM4E (0.58) KDM4ERAB9AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282101-A1 Indazole compounds CYP3A43, CYP3A7, UGT1A1 KDM4E 3676/4885RAB9A 740/4885MEN1 878/4885
US-20120053345-A1 Indazole Compounds CYP3A43, CYP3A7, UGT1A1 KDM4E 3676/4885RAB9A 740/4885MEN1 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.